Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Sponsor
Stephen Freedland
Status
Recruiting
NCT ID
NCT05832086
This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking diet, or usual diet. All patients will receive standard of care treatment for their prostate cancer. The fasting mimicking diet will be consumed for 5 days per month for a total of 6 months and will be monitored by trained research dietitians.

This study aims to examine the effects of a fasting mimicking diet (5 days per month eating L-Nutra products only for 6 months) vs. usual diet on response to cancer treatment of metastatic castrate sensitive prostate adenocarcinoma.
Intervention
Fasting Mimicking Diet (FMD), Standard Anti-Cancer Diet
Condition
Prostate Adenocarcinoma
Investigators
Tanya Dorff, MD, Gillian Gresham, PhD, Mourad Tighiouart, PhD, Sungyong You, PhD, Pao-Hwa Lin, PhD, Daniel George, MD, Matthew Labriola, MD, Edwin Posadas, MD, Stephen Freedland, MD

See list of participating sites